The Obsidio Conformable Embolic recall related to an increased risk for bowel ischemia is the most serious kind, the FDA said on Wednesday, citing two deaths associated with the issue. An ...
Prostate artery embolization (PAE) is a procedure that helps treat urinary symptoms of an enlarged prostate without a risk of sexual side effects. Generally, both Original Medicare (parts A and B) and ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Boston Scientific announced it received FDA 510(k) ...
Boston Scientific Corporation BSX recently announced the acquisition of Obsidio, Inc. This privately-held company is the renowned developer of the FDA-authorized Gel Embolic Material (GEM) technology.
Boston Scientific Corp.’s intent to acquire Penumbra Inc. for $14.5 billion will not only allow it to expand its minimal invasive care portfolio in areas such as embolization and peripheral vascular ...
One of the key drivers of the detachable embolization coils market is the rapid shift toward minimally invasive endovascular therapies. Interventional neuroradiology and vascular surgery departments ...
Prostate artery embolization (PAE) is a procedure that helps treat urinary symptoms of an enlarged prostate without a risk of sexual side effects. Typically, both Original Medicare (parts A and B) and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results